The CEO of Applied DNA Sciences is Exercising Options

By Carrie Williams

Today it was reported that the CEO of Applied DNA Sciences (APDNResearch Report), James Hayward, exercised options to buy 2,935,764 APDN shares at $0.54 a share, for a total transaction value of $1.59M.

This recent transaction increases James Hayward’s holding in the company by 120.73% to a total of $1.94 million. In addition to James Hayward, one other APDN executive reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Based on Applied DNA Sciences’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $2.05 million and GAAP net loss of $1.48 million. In comparison, last year the company earned revenue of $1.02 million and had a GAAP net loss of $2.89 million. Currently, Applied DNA Sciences has an average volume of 473.48K. The company has a one-year high of $1.84 and a one-year low of $0.25.

James Hayward’s trades have generated a 31.0% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion.